How much funding has Character Bio raised?

Character Bio has raised $110.0M in total funding, most recently a Extension Round.

Who are Character Bio's investors?

Character Bio's investors include aMoon, LUMA, Sanofi Ventures, Bausch + Lomb, Jefferson Life Sciences, Innovation Endeavors.

When was Character Bio founded?

Character Bio was founded in 2021.

Where is Character Bio headquartered?

Character Bio is headquartered in San Francisco, California, United States.

What industry is Character Bio in?

Character Bio operates in Artificial Intelligence, Biotech, Data & Analytics.

How many employees does Character Bio have?

Character Bio has 11-50 employees.

Character Bio

Transforming Eye Care With Precision Medicine

San Francisco, United States · Founded 2021 · $110.0M raised

Artificial Intelligence

Biotech

Data & Analytics

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: characterbio.com
Total Funding: $110.0M
Last Round: $17.0M Extension RoundSep 2025
Rounds: 3

About

Character Bio is a precision medicine company focused on progressive polygenic eye diseases, with an initial focus on age-related macular degeneration (AMD) and primary open-angle glaucoma. The company integrates proprietary genomic databases with longitudinal clinical data, imaging, and AI-enabled biomarker quantification to identify patient subtypes and genetic drivers of disease progression. This platform underpins a drug discovery and development pipeline targeting more precise, individualized therapies.

Summary

Character Bio is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. It has raised $110.0M in total across 3 rounds, most recently a $17.0M Extension Round round in Sep 2025. Investors include aMoon, LUMA and Sanofi Ventures.